Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1995-05-10
1998-06-16
Jarvis, William R.A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514188, 514181, 514177, 514178, 514179, 514172, 514174, 514175, A61K 3158, A61K 3156, A61K 31585
Patent
active
057671133
ABSTRACT:
In accordance with the present invention, it has been discovered that certain synthetic steroid compounds are capable of inhibiting the efflux pump which is believed to be responsible for multidrug resistance, while at the same time activating glucocorticoid-induced response. Thus, chemotherapy of glucocorticoid sensitive tumors can be enhanced by use of a compound having the dual ability to activate glucocorticoid-induced response and facilitate the accumulation of drug at the target site, with reduced or eliminated competition by the drug efflux system.
REFERENCES:
patent: 4160452 (1979-07-01), Theeuwes
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4386085 (1983-05-01), Teutsch et al.
patent: 4923871 (1990-05-01), Inaba et al.
patent: 4990538 (1991-02-01), Harris et al.
patent: 5104858 (1992-04-01), Hait et al.
patent: 5114919 (1992-05-01), Baldwin et al.
patent: 5132299 (1992-07-01), Ottow et al.
patent: 5160727 (1992-11-01), Klohs et al.
patent: 5173486 (1992-12-01), Monkovie et al.
patent: 5182293 (1993-01-01), Sunkara et al.
patent: 5190957 (1993-03-01), Sunkara et al.
patent: 5198344 (1993-03-01), Croop et al.
Dalton et al, Medline Abstracts, Abstract No. 89177422, 1989.
Danel-Moore et al, Medline Abstracts, Abstract No. 94097061, 1992.
Agarwal and Khorana "Studies on Polynucleotides. CII. The Use of Aromatic Isocyanates for Selective Blocking of hte Terminal 3'-Hydroxyl Group in Protected Deoxyribooligonucleotides" J. Am. Chem. Soc. 94:3578-3585 (1972).
Barton et al. "Hypophosphorous Acid and its Salts: New Reagents for Radical Chain Deoxygenation, Dehalogenation and Deamination" Tetrahedron Letters 33:5709-5712 (1992).
Barton et al. "The Invention of Radical Reactions. Part XXIV..sup.1 Relative Rates of Acylation and Radical Deoxygenation of Secondary Alcohols" Tetrahedron 48:7435-7446 (1992).
Boden and Keck "Proton-Transfer Steps in Steglich Esterification: A Very Practical New Method for Macrolactonization" J. Org. Chem. 50:2394-2395 (1985).
Efferth and Volm "Rapid Detection Assays for Multidrug Resistance" Arzneim-Forsch 38:1771-1774 (1988).
Ford and Hait "Pharmacology of Drugs That Alter Multidrug Resistance in Cancer" Pharmacological Reviews 42:155-199 (1990).
Goodman and Gilman The Pharmacological basis of Therapeutics, (7th ed.) pp. 1277-1280 (1985).
Gottesman and Pastan "The Multidrug Transporter, a Double-edged Sword" 263:12163-12166 (1988).
Herweijer et al. "A Rapid and Sensitive Flow Cytometric Assay for the Detection of Multidrug Resistant Cells in Human Cancer" Invest. New Drugs 7:442 (1989).
Konen et al. "The Multidrug Transporter: Rapid Modulation of Efflux Activity Monitored in Single Cells by the Morphologic Effects of Vinblastine and Daunomycin" J. Histochem. Cytochem. 37:1141-1145 (1989).
Neises and Steglich "Simple Method for the Esterification of Carboxylic Acids" Agnew. Chem., Int. Ed. Engl. 17:522-524 (1978).
Neises and Steglich "Esterification of Carboxylic Acids with Dicyclohexyl-Carbodiimide/4-Dimethylaminopyridine: tert-Butyl Ethyl Fumarate" W. Org. Synth. 63:183-187 (1984).
Stewart and Evans "Non-chemotherapeutic agents that potentiate chemotherappy efficacy" Cancer Treatment Reviews 16:1-40 (1989).
Twentyman et al. "The in vitro effects and cross-resistance patterns of some novel anthracyclines" Br. J. Cancer 53:585-594 (1986).
Yoshimura et al. "Novel screening method for agents that overcome classical multidrug resistance in a human cell line" Cancer Letters 50:45-51 (1990).
Teutsch et al., "11.beta.-Substituted Steroids, An Original Pathway to Antihormones" J. Steroid Biochem. 31(4B):549-565 (1988).
Cohn Suzanne Bourgeois
Gruol Donald J.
Jarvis William R.A.
Reiter Stephen E.
The Salk Institute for Biological Studies
LandOfFree
Compounds useful for concurrently activating glucocorticoid-indu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds useful for concurrently activating glucocorticoid-indu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful for concurrently activating glucocorticoid-indu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726227